Citation Impact
Citing Papers
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Intratumor microvessel density as a prognostic factor in cancer.
1995
Hallmarks of Cancer: The Next Generation
2011 Standout
Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin
1997
Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
1996
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Clinical translation of angiogenesis inhibitors
2002 Standout
How Tumors Become Angiogenic
1996
Eomesodermin, a Key Early Gene in Xenopus Mesoderm Differentiation
1996 StandoutNobel
Imaging in the era of molecular oncology
2008 StandoutNature
A Xenopus mRNA related to Drosophila twist is expressed in response to induction in the mesoderm and the neural crest
1989 StandoutNobel
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
1999 StandoutNatureNobel
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
1996 StandoutNature
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
1992 StandoutNature
Dynamic control over cell adhesive properties using molecular-based surface engineering strategies
2009 StandoutNobel
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
1994 Standout
Protein‐Reactive Natural Products
2005
Discovery of a New Mechanism and Development of Angiogenic Therapy That Accelerates Healing
1991
An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma
1997
Increased growth and incidence of lymph node metastases due to the angiogenesis inhibitor AGM-1470
1997
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
1995
The microenvironment of the tumour–host interface
2001 StandoutNature
Clinical Applications of Research on Angiogenesis
1995 Standout
Inhibition of Angiogenesis by the Antifungal Drug Itraconazole
2007
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Mechanisms of angiogenesis
1997 StandoutNature
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma
1997
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
2003
Okadaic Acid Is a Potent Angiogenesis Inducer
1992
Molecular Basis for Species-Specific Sensitivity to “Hot” Chili Peppers
2002 StandoutNobel
Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.
1998
Effect of Antiangiogenic Therapy on Slowly Growing, Poorly Vascularized Tumors in Mice
2001
Analysis of experimental antiangiogenic therapy
1993
Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
1991
Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis
1991
Structure/Activity Relationships in Basic FGF
1991
Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents
1994
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
1996 StandoutNature
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
1994 StandoutNature
Angiogenesis as a therapeutic target
2005 StandoutNature
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
1993 StandoutNature
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
1997 StandoutScience
Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor.
1991
A systems approach to cancer therapy
1996
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice
1999
The Fgf Family of Growth Factors and Oncogenes
1992
Electrochemical Desorption of Self-Assembled Monolayers Noninvasively Releases Patterned Cells from Geometrical Confinements
2003
Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
1993
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
1997 StandoutScience
Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth
1998
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
Angiogenesis inhibition suppresses collagen arthritis.
1992
Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity.
1994
A model of angiogenesis in the mouse cornea.
1996
Wound Healing--Aiming for Perfect Skin Regeneration
1997 StandoutScience
Ribosomal Synthesis of Dehydroalanine-Containing Peptides
2006 StandoutNobel
Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy
1994
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
1998 StandoutNobel
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
1999 StandoutScience
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470.
2003
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
1999 Science
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
1997 StandoutNobel
Angiogenesis
2006
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
2000
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
1992 StandoutScience
Multi-Institutional Study of the Angiogenesis Inhibitor TNP-470 in Metastatic Renal Carcinoma
1999
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
1993
Requirement of Vascular Integrin α v β 3 for Angiogenesis
1994 StandoutScience
The Molecular Biology of Axon Guidance
1996 StandoutScience
Chemical Characterization of a Family of Brain Lipids That Induce Sleep
1995 Science
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Geometric Control of Cell Life and Death
1997 StandoutScience
Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.
2001
Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature.
1998
The Presence of Fibroblast Growth Factor in the Frog Egg: Its Role as a Natural Mesoderm Inducer
1988 Science
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Angiogenesis.
1992 Standout
Works of Katsuichi Sudo being referenced
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
1990 Nature
Isolation of fatty acid amide as an angiogenic principle from bovine mesentery
1990
Stabilizing basic fibroblast growth factor using protein engineering
1988
Angiogenic activity of the recombinant hst-1 protein
1994
Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent
1991
Antiestrogen pharmacology and mechanism of action
1983